标题
The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 21, Issue 4, Pages R331-R344
出版商
Bioscientifica
发表日期
2014-07-23
DOI
10.1530/erc-14-0188
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Expression of DNA repair proteins in endometrial cancer predicts disease outcome
- (2014) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
- (2013) Howard A. Burris CANCER CHEMOTHERAPY AND PHARMACOLOGY
- mTOR is Frequently Active in GH-Secreting Pituitary Adenomas without Influencing their Morphopathological Features
- (2013) Emir Ahmed Sajjad et al. ENDOCRINE PATHOLOGY
- Inhibition of PI3K/AKT/mTOR Pathway Enhances Temozolomide-Induced Cytotoxicity in Pituitary Adenoma Cell Lines in Vitro and Xenografted Pituitary Adenoma in Female Nude Mice
- (2013) Congxin Dai et al. ENDOCRINOLOGY
- Apoptosis: its role in pituitary development and neoplastic pituitary tissue
- (2013) M. F. Guzzo et al. Pituitary
- Extended endoscopic endonasal skull base surgery: from the sella to the anterior and posterior cranial fossa
- (2012) Amanda Oostra et al. ANZ JOURNAL OF SURGERY
- Clinicopathological Correlations in Pituitary Adenomas
- (2012) Ozgur Mete et al. BRAIN PATHOLOGY
- Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
- (2012) C.B. Murat et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- The FGFR4-G388R Single-Nucleotide Polymorphism Alters Pancreatic Neuroendocrine Tumor Progression and Response to mTOR Inhibition Therapy
- (2012) S. Serra et al. CANCER RESEARCH
- Nelfinavir induces radiation sensitization in pituitary adenoma cells
- (2011) Jing Zeng et al. CANCER BIOLOGY & THERAPY
- Cooperativity within and among Pten, p53, and Rb Pathways Induces High-Grade Astrocytoma in Adult Brain
- (2011) Lionel M.L. Chow et al. CANCER CELL
- Expression and function of ErbB receptors and ligands in the pituitary
- (2011) Odelia Cooper et al. ENDOCRINE-RELATED CANCER
- Levels of p27 Sensitize to Dual PI3K/mTOR Inhibition
- (2011) M. Lee et al. MOLECULAR CANCER THERAPEUTICS
- The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis
- (2011) Toru Tateno et al. PLoS Genetics
- The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
- (2010) V. Cerovac et al. CANCER RESEARCH
- Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer
- (2010) Yoshio Yoshida et al. EUROPEAN JOURNAL OF CANCER
- Temozolomide-induced inhibition of pituitary adenoma cells
- (2010) Jason Sheehan et al. JOURNAL OF NEUROSURGERY
- HER2/ErbB2 Receptor Signaling in Rat and Human Prolactinoma Cells: Strategy for Targeted Prolactinoma Therapy
- (2010) Hidenori Fukuoka et al. MOLECULAR ENDOCRINOLOGY
- The clinical significance of MIB-1 labeling index in pituitary adenomas
- (2010) Geeta Chacko et al. Pituitary
- The Pathogenesis of Pituitary Tumors
- (2009) Sylvia L. Asa et al. Annual Review of Pathology-Mechanisms of Disease
- Relation between outcomes and localisation of p-mTOR expression in gastric cancer
- (2009) T Murayama et al. BRITISH JOURNAL OF CANCER
- Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
- (2009) Alexander Gorshtein et al. ENDOCRINE-RELATED CANCER
- Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors
- (2009) D Dworakowska et al. ENDOCRINE-RELATED CANCER
- Platelet-derived Growth Factor (PDGF) and PDGF Receptor Expression and Function in Folliculostellate Pituitary Cells
- (2009) M. Kowarik et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Predicting Recurrence of Nonfunctioning Pituitary Adenomas
- (2009) Tae-Woong Noh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
- (2009) Maria Chiara Zatelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin
- (2009) Christoph Lahtz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Fibroblast growth factor receptor–3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase–Akt pathway
- (2009) Mahlon D. Johnson et al. JOURNAL OF NEUROSURGERY
- Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor Ligands
- (2008) G. Vlotides et al. CANCER RESEARCH
- PIK3CA Cooperates with Other Phosphatidylinositol 3'-Kinase Pathway Mutations to Effect Oncogenic Transformation
- (2008) K. Oda et al. CANCER RESEARCH
- Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors
- (2008) Yong Lin et al. ENDOCRINE-RELATED CANCER
- Activation of Phosphatidylinositol 3-Kinase Signaling Promotes Aberrant Pituitary Growth in a Mouse Model of Thyroid-Stimulating Hormone-Secreting Pituitary Tumors
- (2008) Changxue Lu et al. ENDOCRINOLOGY
- Dose-Dependent Effects of Radiation Therapy on Cerebral Blood Flow, Metabolism, and Neurocognitive Dysfunction
- (2008) Carol A. Hahn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search